Introduction and Objectives: While recommended blood glucose monitoring (BGM) frequency varies by therapy and individual circumstances, many people with type 2 diabetes (T2D) may not follow suggested monitoring guidelines. Given recent advancements in blood glucose monitoring technology, we studied the impact of connecting a BG meter to a mobile diabetes self-management app (mySugr®) on testing frequency and glycemic control.

Methods: We performed a retrospective analysis of 103,400 mySugr app users in the United States with self-reported T2D who were enrolled between January, 2018 and November, 2023 and calculated the change in BG testing frequency and mean BG per 30-day period in the 180 days following glucometer connection to mySugr to the 30-day period prior to connection. We also analyzed the impact of BG logging frequency on the change in glycemic control.

Results: Following enrollment in the app, users increased the frequency of BG testing from a baseline of 19.87 logs (95% CI 19.61-20.15) in the 30-day period prior to mySugr connection to 52.38 BG logs (52.02-52.74) in days 0-30 following connection and 32.57 logs (32.27-32.86) at 150-180 days. Mean BG was 175.87 mg/dL (175.43-176.36) at baseline and 143.99 mg/dL (143.62 - 144.38) at 180 days following connection to mySugr. Users who logged greater than 30 logs between 150 and 180 days after registration had a greater reduction of mean BG (-20.44 mg/dL [-19.70 - -21.22]) than those with 30 or fewer logs (-18.35 mg/dL [-17.78 - -18.95]).

Conclusion: Following glucometer connection to the mySugr app, users recorded significantly more BG logs up to 180 days following connection. Use of the mySugr app was associated with a significant reduction in mean BG, and users who recorded > 30 logs/30 days achieved a greater reduction in mean BG vs. those who recorded <= 30 logs/30 days.

Disclosure

B. Ulmer: Employee; Roche Diabetes Care. B. Ruch: Employee; Roche Diabetes Care. E. Repetto: Employee; Roche Diabetes Care.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.